# Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors

**Authors:** Chengcheng Zhang, Yubo He, Xiaoye Liu, Jingjing Xie, Meng Fang, Xing Yang, Ryan Huang, Qi Lou, Bufan Li, Ankit Gupta, Cheryl Lewis, Marc I. Diamond, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang

PMC · DOI: 10.1038/s41392-025-02462-x · 2025-11-14

## TL;DR

Oligomeric cystatin C boosts immunosuppression in myeloid cells, promoting tumor growth through interactions with immune receptors.

## Contribution

This study identifies a novel immunosuppressive role of oligomeric cystatin C through LILRB2 and LILRB5 receptors in myeloid cells.

## Key findings

- Oligomeric cystatin C interacts with LILRB2 and LILRB5 to enhance myeloid cell immunosuppression.
- Cystatin C–LILRB2 signaling involves phosphatases and the TGF-β pathway.
- Deleting the CST3 gene reduced tumor growth, while overexpression accelerated cancer progression.

## Abstract

Amyloid proteins are linked to various diseases; however, their functional roles in immunity and cancer remain unclear. Here, we establish a direct link between oligomeric cystatin C—a cysteine cathepsin inhibitor and a well-characterized amyloidogenic protein—within the tumor microenvironment and the immune inhibitory receptors LILRB2 and LILRB5 on myeloid cells. We demonstrated that human LILRB2 and LILRB5, along with their murine counterpart PIRB, serve as functional receptors for cystatin C oligomers. Engagement of these inhibitory receptors by oligomeric cystatin C enhances the immunosuppressive activity of myeloid cells, leading to T-cell suppression and tumor progression. Deletion of the CST3 gene, which encodes cystatin C, in host mice and tumor cells impaired tumor growth, whereas its overexpression accelerated cancer progression in LILRB2 and LILRB5 transgenic mice. Mechanistically, cystatin C–LILRB2 signaling is driven by both canonical phosphatases and the enhanced TGF-β pathway. Additionally, we identified interactions between LILRB receptors and transthyretin oligomers, another amyloid linked to transthyretin amyloidosis, suggesting a broader paradigm of amyloid–LILRB interactions. Our findings reveal an unexpected role of oligomeric cystatin C in enhancing myeloid cell immunosuppression, expand the functional spectrum of amyloid proteins and underscore the importance of these proteins in immune evasion and cancer development.

## Linked entities

- **Genes:** CST3 (cystatin C) [NCBI Gene 1471], LILRB2 (leukocyte immunoglobulin like receptor B2) [NCBI Gene 10288], LILRB5 (leukocyte immunoglobulin like receptor B5) [NCBI Gene 10990], LILRB1 (leukocyte immunoglobulin like receptor B1) [NCBI Gene 10859]
- **Proteins:** CYSTATIN-C (cystatin-C), LILRB2 (leukocyte immunoglobulin like receptor B2), LILRB5 (leukocyte immunoglobulin like receptor B5), LILRB1 (leukocyte immunoglobulin like receptor B1)
- **Diseases:** cancer (MONDO:0004992)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Cst3 (cystatin C) [NCBI Gene 13010] {aka CysC}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Pirb (paired Ig-like receptor B) [NCBI Gene 18733] {aka Gp91, LIR-3, Lilrb3, PIR-B}, Ttr (transthyretin) [NCBI Gene 22139] {aka prealbumin}
- **Diseases:** transthyretin amyloidosis (MESH:C567782), cancer (MESH:D009369)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12615798/full.md

---
Source: https://tomesphere.com/paper/PMC12615798